Literature DB >> 25933640

Decreased Interferon γ Production in CD3+ and CD3- CD56+ Lymphocyte Subsets in Metastatic Regional Lymph Nodes of Melanoma Patients.

Ana Vuletić1, Irena Jovanić, Vladimir Jurišić, Zorka Milovanović, Srđan Nikolić, Igor Spurnić, Gordana Konjević.   

Abstract

As lymphogenic dissemination is very common in melanoma, regional lymph nodes (LN)s represent first immunological barriers to tumor invasion and play a complex role in antitumor immune defense. In this sense, their most prominent role is the presentation of tumor-derived antigens to naïve T cells and generation of cell-mediated adaptive immune response. Since tumor micro-environment affects immune cell function in this study we have evaluated the ability of T cells and NK cells in metastatic (involved) and non-metastatic regional LNs to produce interferon γ (IFNγ), a pleiotropic cytokine that regulates adaptive antitumor immune response. Our results show reduced IFNγ production in both T and NK lymphocyte subsets and decreased prevalence of T cells in metastatic regional LNs of melanoma patients. The decrease of IFNγ production in T cells was more pronounced with increased number of involved regional LNs indicating tumor-induced functional impairment of both T and NK cell lymphocyte subsets in involved regional LNs. Therefore, shown low IFNγ production in metastatic LNs may represent an obstacle in adaptive cell-mediated antitumor immune response and hence may enable tumor progression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25933640     DOI: 10.1007/s12253-015-9938-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  20 in total

1.  NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.

Authors:  Barbara Morandi; Lorenzo Mortara; Paolo Carrega; Claudia Cantoni; Gregorio Costa; Roberto S Accolla; Maria Cristina Mingari; Silvano Ferrini; Lorenzo Moretta; Guido Ferlazzo
Journal:  Int Immunol       Date:  2009-03-26       Impact factor: 4.823

2.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

3.  NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion.

Authors:  Barbara Morandi; Gwenola Bougras; William A Muller; Guido Ferlazzo; Christian Münz
Journal:  Eur J Immunol       Date:  2006-09       Impact factor: 5.532

Review 4.  Tumour-induced immune modulation of sentinel lymph nodes.

Authors:  Alistair J Cochran; Rong-Rong Huang; Jonathan Lee; Eijun Itakura; Stanley P L Leong; Richard Essner
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

Review 5.  The two faces of interferon-γ in cancer.

Authors:  M Raza Zaidi; Glenn Merlino
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

6.  DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.

Authors:  Christian Adam; Susan King; Thomas Allgeier; Heidi Braumüller; Carolin Lüking; Josef Mysliwietz; Anja Kriegeskorte; Dirk H Busch; Martin Röcken; Ralph Mocikat
Journal:  Blood       Date:  2005-03-15       Impact factor: 22.113

7.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15.

Authors:  Mathias Lucas; William Schachterle; Karin Oberle; Peter Aichele; Andreas Diefenbach
Journal:  Immunity       Date:  2007-03-29       Impact factor: 31.745

8.  Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma.

Authors:  Wendy K Nevala; Celine M Vachon; Alexey A Leontovich; Christopher G Scott; Michael A Thompson; Svetomir N Markovic
Journal:  Clin Cancer Res       Date:  2009-02-24       Impact factor: 12.531

9.  Natural killer cell distribution and trafficking in human tissues.

Authors:  Paolo Carrega; Guido Ferlazzo
Journal:  Front Immunol       Date:  2012-11-29       Impact factor: 7.561

Review 10.  IFN inducibility of major histocompatibility antigens in tumors.

Authors:  Barbara Seliger; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

View more
  8 in total

1.  IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients.

Authors:  Ana Vuletić; Irena Jovanić; Vladimir Jurišić; Zorka Milovanović; Srđan Nikolić; Igor Spurnić; Gordana Konjević
Journal:  Pathol Oncol Res       Date:  2018-06-11       Impact factor: 3.201

2.  Lymphadenectomy is associated with poor survival in patients with gastrointestinal stromal tumors.

Authors:  Cong Li; Dongfang Su; Chuanbo Xie; Qichen Chen; Jianguo Zhou; Xiaojun Wu
Journal:  Ann Transl Med       Date:  2019-10

3.  Functional Change of Effector Tumor-Infiltrating CCR5+CD38+HLA-DR+CD8+ T Cells in Glioma Microenvironment.

Authors:  Pin-Yuan Chen; Caren Yu-Ju Wu; Jian-He Fang; Hsiu-Chi Chen; Li-Ying Feng; Chiung-Yin Huang; Kuo-Chen Wei; Jia-You Fang; Chun-Yen Lin
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

4.  A novel nomogram for predicting liver metastasis in patients with gastrointestinal stromal tumor: a SEER-based study.

Authors:  Guowei Zhou; Keshuai Xiao; Guanwen Gong; Jiabao Wu; Ya Zhang; Xinxin Liu; Zhiwei Jiang; Chaoqun Ma
Journal:  BMC Surg       Date:  2020-11-25       Impact factor: 2.102

Review 5.  The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs).

Authors:  Payam Behzadi; Aga Syed Sameer; Saniya Nissar; Mujeeb Zafar Banday; Márió Gajdács; Herney Andrés García-Perdomo; Kulsum Akhtar; Marina Pinheiro; Peter Magnusson; Meysam Sarshar; Cecilia Ambrosi
Journal:  J Immunol Res       Date:  2022-03-26       Impact factor: 4.818

Review 6.  Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity.

Authors:  Alberto Mendoza-Valderrey; Maite Alvarez; Andrea De Maria; Kim Margolin; Ignacio Melero; Maria Libera Ascierto
Journal:  Cells       Date:  2022-10-06       Impact factor: 7.666

7.  Memory-like Differentiation Enhances NK Cell Responses to Melanoma.

Authors:  Nancy D Marin; Bradley A Krasnick; Michelle Becker-Hapak; Leah Conant; Simon P Goedegebuure; Melissa M Berrien-Elliott; Keenan J Robbins; Jennifer A Foltz; Mark Foster; Pamela Wong; Celia C Cubitt; Jennifer Tran; Christopher B Wetzel; Miriam Jacobs; Alice Y Zhou; David Russler-Germain; Lynne Marsala; Timothy Schappe; Ryan C Fields; Todd A Fehniger
Journal:  Clin Cancer Res       Date:  2021-06-29       Impact factor: 12.531

8.  Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma-A Real World Single-Center Analysis.

Authors:  Michèle Hoffmann; Stefanie Hayoz; Berna C Özdemir
Journal:  Biology (Basel)       Date:  2022-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.